Project Title

A multicentre, observational, prospective study of the current practice in major centres in Australia and New Zealand for achieving haemostasis in consecutive patients who present with significant haemorrhage, thromboembolism or urgent surgery whilst on new or established oral anticoagulants.

Official Title

A multicentre, observational, prospective study of the current practice in major centres in Australia and New Zealand for achieving haemostasis in consecutive patients who present with significant haemorrhage, thromboembolism or urgent surgery whilst on new or established oral anticoagulants.

Project Summary

This is an observational study to document in major centres in Australia and New Zealand the current practice for achieving haemostasis in patients who present with significant haemorrhage, thromboembolism or require anticoagulant reversal for urgent surgery and/or a procedure whilst on new (dabigatran, rivaroxaban, or apixaban) or established (warfarin) oral anticoagulants. The duration of the study is 42 months.

Blood Disorder

• Microangiopathic Thrombocytopenia (including Thrombotic Thrombocytopaenic Pupura and Atypical Hemolytic Uremic Syndrome) 

Patient Recruitment Details

Patient recruitment status: Open

Number of Patients

300 participants.

Supporting Organisations

• Asian-Pacific Microangiopathic Thrombocytopenia Network